UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say

UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say

A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota.  Stephen Maturen | Getty Images UnitedHealthcare is offering certain employees in its benefits operations unit the option to accept buyouts if they quit by March 3, following a tumultuous year for the insurance giant, CNBC has learned. Those who…

Read More
Innovaccer launches AI agents for doctors and hospitals to address burnout

Innovaccer launches AI agents for doctors and hospitals to address burnout

Innovaccer CEO Abhinav Shashank. Courtesy: Innovaccer As doctors and nurses face historic rates of burnout, Innovacer says artificial intelligence is here to help. The health-care data company on Monday announced a suite of AI agents that are designed to automate repetitive, “low-value” tasks for clinicians.  “We just don’t have enough capacity in the health system to…

Read More
Neuralink competitor Paradromics secures investment from Saudi Arabia’s Neom

Neuralink competitor Paradromics secures investment from Saudi Arabia’s Neom

Paradromics’ Connexus Brain-Computer Interface. Courtesy: Paradromics Texas-based neurotech startup Paradromics on Wednesday announced a strategic partnership with Saudi Arabia’s Neom and said it will establish a Brain-Computer Interface Center of Excellence in the region. Neom is a developing area within northwest Saudi Arabia that’s touted as “a hub for innovation,” according to its website. The…

Read More
CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic’ practices

CVS CEO defends pharmacy middlemen, accuses drugmakers of ‘monopolistic’ practices

David Joyner, a longtime CVS executive, speaks during a Senate Health, Education, Labor and Pensions Committee hearing in Washington, D.C., on May 10, 2023. Al Drago | Bloomberg | Getty Images CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s Caremark unit, which are widely accused of inflating prescription medication…

Read More
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short 

Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short 

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth.  But the biotech company’s…

Read More